{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T10:30:52Z","timestamp":1774780252558,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cocaine intoxication and abuse is a worldwide problem that can be the cause of numerous acute medical complications, including severe acute hepatitis. Although these cases are scarce, they are extremely serious and may lead to liver transplantation or death. Management of toxic hepatitis, once the causative agent has been discontinued, is essentially symptomatic, based on clinical and biological monitoring and prevention of complications related to acute hepatitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case details<\/jats:title><jats:p>We present a case of a 28-year-old woman admitted to the emergency department for acute hepatitis due to cocaine intoxication. In addition to a sharp rise in her liver enzymes, the patient also presented metabolic acidosis, renal failure, and rhabdomyolysis. Treatment consisted of administering N-acetylcysteine (NAC), dialysis, and additional supportive measures. An improvement in the liver function with a decrease in transaminases occurred after the NAC administration. The toxicokinetics of major cocaine metabolites and clinical chemistry concentrations were monitored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In addition to the usual management measures for acute hepatitis, the administration of N-acetylcysteine should be investigated further, although it is currently used only in cases of acetaminophen acute toxic hepatitis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/ftox.2024.1502716","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:12:10Z","timestamp":1736921530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["N-acetylcysteine use in a cocaine-induced liver failure: a case report"],"prefix":"10.3389","volume":"6","author":[{"given":"Vanessa","family":"Biering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Bellouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00eblle","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Dailly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Monteil-Gani\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard Charles","family":"Le Carpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","article-title":"Drug induced liver injury - a 2023 update","volume":"26","author":"Allison","year":"2023","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40261-017-0505-4","article-title":"Effect of N-acetylcysteine on mortality and liver transplantation rate in non-acetaminophen-induced acute liver failure: a multicenter study","volume":"37","author":"Darweesh","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"B3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.drugalcdep.2016.04.004","article-title":"Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration","volume":"163","author":"Ellefsen","year":"2016","journal-title":"Drug Alcohol Dependence"},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s1665-2681(19)32120-9","article-title":"A concise and structured review of drug-induced toxic hepatic disease","volume":"3","author":"Fernando Sierra","year":"2004","journal-title":"Ann. Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.clinre.2015.01.003","article-title":"Efficacy and safety of acetylcysteine in \u201cnon-acetaminophen\u201d acute liver failure: a meta-analysis of prospective clinical trials","volume":"39","author":"Hu","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.3390\/ijms24021632","article-title":"Cocaine-induced time-dependent alterations in cytochrome P450 and liver function","volume":"24","author":"Jastrz\u0119bska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/lt.21246","article-title":"Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure","volume":"14","author":"Kortsalioudaki","year":"2008","journal-title":"Liver Transpl."},{"key":"B8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/15287390306370","article-title":"N -acetylcysteine pretreatment decreases cocaine and endotoxin-induced hepatotoxicity","volume":"66","author":"Labib","year":"2003","journal-title":"J. Toxicol. Environ. Health, Part A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","article-title":"Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure","volume":"137","author":"Lee","year":"2009","journal-title":"Gastroenterology"},{"key":"B10","volume-title":"AASLD position paper: the management of acute liver failure: update 201","author":"Lee","year":"2011"},{"key":"B11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.toxac.2015.04.011","article-title":"N-ac\u00e9tylcyst\u00e9ine pour l\u2019intoxication au parac\u00e9tamol: qui traiter et selon quel sch\u00e9ma optimal","volume":"27","author":"M\u00e9garbane","year":"2015","journal-title":"Toxicol. Anal. Clinique"},{"key":"B12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12072-009-9151-0","article-title":"Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation","volume":"3","author":"Mumtaz","year":"2009","journal-title":"Hepatol. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/1319-3767.207711","article-title":"Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: a prospective study","volume":"23","author":"Nabi","year":"2017","journal-title":"Saudi J. Gastroenterol."},{"key":"B14","first-page":"8","volume-title":"Drogues et addictions chiffres cl\u00e9s","year":"2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.accpm.2019.06.014","article-title":"Management of liver failure in general intensive care unit","volume":"39","author":"Paugam-Burtz","year":"2020","journal-title":"Anaesth. Crit. Care & Pain Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2174\/1570159X19666201230144109","article-title":"The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress","volume":"19","author":"Raghu","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"876868","DOI":"10.3389\/fphar.2022.876868","article-title":"N-acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults: a systematic review","volume":"13","author":"Sanabria-Cabrera","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0168-8278(91)90832-v","article-title":"Hepatic dysfunction accompanying acute cocaine intoxication","volume":"12","author":"Silva","year":"1991","journal-title":"J. Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/hep.26001","article-title":"Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial","volume":"57","author":"Squires","year":"2013","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/antiox10060967","article-title":"N-acetylcysteine (NAC): impacts on human health","volume":"10","author":"Ten\u00f3rio","year":"2021","journal-title":"Antioxidants"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.2174\/092986712803988938","article-title":"Contribution of oxidative metabolism to cocaine-induced liver and kidney damage","volume":"19","author":"Valente","year":"2012","journal-title":"CMC"}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2024.1502716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:12:12Z","timestamp":1736921532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2024.1502716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":21,"alternative-id":["10.3389\/ftox.2024.1502716"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2024.1502716","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1502716"}}